Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
Abstract:
The present disclosure relates, in general, to methods of treating or preventing hypoglycemia using a negative modulator antibody fragment that binds to the insulin receptor and modulates the action of insulin at the insulin receptor.
Information query
Patent Agency Ranking
0/0